Skip to main content
Skip to section navigation
Skip to footer
Home
About Us
Overview
Management Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Our Science
Product Pipeline
Overview
PMN310 | Amyloid-Beta
PMN267 | TDP-43
PMN442 | Alpha-Synuclein
Vaccines
Posters & Publications
Clinical Trials
Investors
Overview
News & Events
Company Info
Financial Results
Stock Data
SEDAR
SEC Filings
Governance
Contact
IR Calendar
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Results
Stock Data
NASDAQ: PMN
Analyst Coverage
SEDAR
SEC Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
H.C. Wainwright & Co., 21st Annual Investment Conference
September 10, 2019 10:25 am EDT
Webcast
Email Alerts
Contacts